Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.99.1 (
NADPH-diaphorase
)
3,903
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nitric oxide (NO) is formed constitutively in neurons by the constitutive enzyme NO synthase (cNOS) and acts as a neurotransmitter. It has already been shown that cNOS-containing neurons are identical to neurons staining for
NADPH diaphorase
and vice versa. Effector cells of the immune response produce high NO levels after appropriate stimulation and this NO is formed by inducible NO synthase (iNOS). The NO produced by macrophages is considered an important effector molecule of antimicrobial host defence. We have applied
NADPH diaphorase
staining for the detection of NO producing cells in situ during infection with an intracellular pathogen. Macrophages which produce NO in vitro are stained for
NADPH diaphorase
. Expression of iNOS mRNA and macrophage
NADPH diaphorase
staining was inhibited by iNOS-specific antisense oligonucleotides. These data suggest coincidental similarity between
NADPH diaphorase
activity and NO production by macrophages. Cells staining for
NADPH diaphorase
were identified in cryostat frozen sections of livers from mice infected with the intracellular pathogen, Listeria monocytogenes, and co-localized with cells labelled by
MAC-1
mAbs. The purple-blue reaction product of
NADPH diaphorase
staining was visible in discrete granulomatous lesions but was absent from the liver parenchyma. Our results provide direct evidence for localized and transient participation of NO in antimicrobial immunity in the infected organ. This restriction may focus NO production to lesions, leaving unrelated tissue sites unaffected.
...
PMID:NADPH diaphorase staining suggests a transient and localized contribution of nitric oxide to host defence against an intracellular pathogen in situ. 753 30
N-Methyl-d-aspartate (NMDA)-induced striatal excitotoxicity is mediated by nitric oxide (NO) but the role of inflammatory mechanisms and inducible nitric oxide synthase (iNOS) induction is not clear. Unilateral intrastriatal administration of NMDA to rats resulted in the loss of intrinsic striatal neurones and the degeneration of
NADPH-diaphorase
positive interneurones within 24 h. NMDA administration caused activation of glial fibrillary acidic protein positive astroglial cells and
MAC-1
ir microglia. Marked iNOS immunoreactivity was expressed within both astroglial and microglial cells and there was marked cellular labelling for 3-nitrotyrosine (3-NT). One month following the NMDA lesion, administration of (+)-amphetamine (AMPH) produced a circling response in rats. Pre-treatment of rats with the iNOS inhibitor aminoguanidine (AG) decreased the extent of NMDA-induced striatal cell loss at 24 h and reduced 3-NT expression but was without effect on glial cell activation. AG pre-treatment also prevented the onset of rotation to AMPH at 30 days following NMDA lesioning. NMDA administration unexpectedly caused a loss of tyrosine hydroxylase immunoreactive (TH-ir) fibres in the striatum at 24 h and at 30 days the number of TH-ir cells were decreased in the substantia nigra. The loss of nigral cells was prevented by AG pre-treatment. This study demonstrates a role for iNOS induction in NO-mediated NMDA excitotoxicity to rat striatum and suggests that inflammatory mechanisms play a key role in this process.
...
PMID:Role of inducible nitric oxide synthase in N-methyl-d-aspartic acid-induced strio-nigral degeneration. 1553 21